High-Infiltration of Tumor-Associated Macrophages Predicts Unfavorable Clinical Outcome for Node-Negative Breast Cancer

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Zhang, Yue ^a   Cheng, Shaoqiang ^a   Zhang, Mingyan ^a   Zhen, Lina ^a   Pang, Da ^a   Zhang, Qingyuan ^a   Li, Zhigao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER TISSUE; CELL DENSITY; CELL INFILTRATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; RETROSPECTIVE STUDY; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84884755261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076147     Document Type: Article

References (36)

1. Witz IP, Levy-Nissenbaum O, (2006) The tumor microenvironment in the post-PAGET era. Cancer Lett 242: 1-10.
2. Joyce JA, Pollard JW, (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252.
3. Li H, Fan X, Houghton J, (2007) Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 101: 805-815.
4. Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ, (2013) The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 138: 105-115.
5. Becker JC, Andersen MH, Schrama D, Thor Straten P (2013) Immune-suppressive properties of the tumor microenvironment. Cancer Immunol Immunother.
6. Allavena P, Sica A, Garlanda C, Mantovani A, (2008) The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222: 155-161.
7. Tang X, (2013) Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett 332: 3-10.
8. Mantovani A, Sica A, (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22: 231-237.
9. Laoui D, Movahedi K, Van Overmeire E, Van den Bossche J, Schouppe E, et al. (2011) Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int J Dev Biol 55: 861-867.
10. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
11. Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH, et al. (2012) Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One 7: e50946.
12. Kong LQ, Zhu XD, Xu HX, Zhang JB, Lu L, et al. (2013) The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma. PLoS One 8: e59771.
13. Bolat F, Kayaselcuk F, Nursal TZ, Yagmurdur MC, Bal N, et al. (2006) Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res 25: 365-372.
14. Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ, (2011) Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn 11: 91-100.
15. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, et al. (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14: 425-431.
16. Medrek C, Ponten F, Jirstrom K, Leandersson K, (2012) The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 12: 306.
17. Siegel R, Naishadham D, Jemal A, (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
18. Adam Maciejczyk A, (2013) New prognostic factors in breast cancer. Adv Clin Exp Med 22: 5-15.
19. Karlsson E, Danielsson A, Delle U, Olsson B, Karlsson P, et al. (2007) Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer. Cancer Genet Cytogenet 172: 139-146.
20. Yoshikawa K, Mitsunaga S, Kinoshita T, Konishi M, Takahashi S, et al. (2012) Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head. Cancer Sci 103: 2012-2020.
21. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E, (2012) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23Suppl 7: vii11-19.
22. Smith RA, Duffy SW, Tabar L (2012) Breast cancer screening: the evolving evidence. Oncology (Williston Park) 26: 471-475, 479-481, 485-476.
23. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
24. Murray PJ, Wynn TA, (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737.
25. Sica A, Mantovani A, (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795.
26. Ong SM, Tan YC, Beretta O, Jiang D, Yeap WH, et al. (2012) Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur J Immunol 42: 89-100.
27. Connelly L, Barham W, Onishko HM, Chen L, Sherrill TP, et al. (2011) NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model. Breast Cancer Res 13: R83.
28. Biswas SK, Mantovani A, (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896.
29. Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, et al. (2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012: 948098.
30. Pollard JW, (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78.
31. Kimura YN, Watari K, Fotovati A, Hosoi F, Yasumoto K, et al. (2007) Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci 98: 2009-2018.
32. Coffelt SB, Hughes R, Lewis CE, (2009) Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 1796: 11-18.
33. Biswas SK, Allavena P, Mantovani A (2013) Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin Immunopathol.
34. Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, et al. (2012) Tumour-infiltrating macrophages and clinical outcome in breast cancer. J Clin Pathol 65: 159-163.
35. Harbeck N, Thomssen C, (2011) A new look at node-negative breast cancer. Oncologist 16Suppl 1: 51-60.
36. Brouckaert O, Schoneveld A, Truyers C, Kellen E, Van Ongeval C, et al. (2013) Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers. Ann Oncol.